chr8-67190742-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001382391.1(CSPP1):​c.3313T>C​(p.Trp1105Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.013 in 1,610,886 control chromosomes in the GnomAD database, including 510 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.022 ( 80 hom., cov: 32)
Exomes 𝑓: 0.012 ( 430 hom. )

Consequence

CSPP1
NM_001382391.1 missense

Scores

15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.43

Publications

12 publications found
Variant links:
Genes affected
CSPP1 (HGNC:26193): (centrosome and spindle pole associated protein 1) This gene encodes a centrosome and spindle pole associated protein. The encoded protein plays a role in cell-cycle progression and spindle organization, regulates cytokinesis, interacts with Nephrocystin 8 and is required for cilia formation. Mutations in this gene result in primary cilia abnormalities and classical Joubert syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Apr 2014]
ARFGEF1 (HGNC:15772): (ADP ribosylation factor guanine nucleotide exchange factor 1) ADP-ribosylation factors (ARFs) play an important role in intracellular vesicular trafficking. The protein encoded by this gene is involved in the activation of ARFs by accelerating replacement of bound GDP with GTP. It contains a Sec7 domain, which may be responsible for guanine-nucleotide exchange activity and also brefeldin A inhibition. [provided by RefSeq, Aug 2011]
ARFGEF1 Gene-Disease associations (from GenCC):
  • developmental delay, impaired speech, and behavioral abnormalities, with or without seizures
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics, G2P
  • schizophrenia
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0013003945).
BP6
Variant 8-67190742-T-C is Benign according to our data. Variant chr8-67190742-T-C is described in ClinVar as [Benign]. Clinvar id is 379419.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0222 (3375/152242) while in subpopulation SAS AF = 0.0462 (223/4824). AF 95% confidence interval is 0.0413. There are 80 homozygotes in GnomAd4. There are 2004 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 80 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CSPP1NM_001382391.1 linkc.3313T>C p.Trp1105Arg missense_variant Exon 29 of 31 ENST00000678616.1 NP_001369320.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CSPP1ENST00000678616.1 linkc.3313T>C p.Trp1105Arg missense_variant Exon 29 of 31 NM_001382391.1 ENSP00000504733.1 A0A7I2V5W3

Frequencies

GnomAD3 genomes
AF:
0.0222
AC:
3372
AN:
152124
Hom.:
80
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0344
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0107
Gnomad ASJ
AF:
0.00605
Gnomad EAS
AF:
0.0119
Gnomad SAS
AF:
0.0466
Gnomad FIN
AF:
0.101
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.00536
Gnomad OTH
AF:
0.0181
GnomAD2 exomes
AF:
0.0223
AC:
5559
AN:
249492
AF XY:
0.0228
show subpopulations
Gnomad AFR exome
AF:
0.0363
Gnomad AMR exome
AF:
0.00959
Gnomad ASJ exome
AF:
0.00636
Gnomad EAS exome
AF:
0.0127
Gnomad FIN exome
AF:
0.0973
Gnomad NFE exome
AF:
0.00718
Gnomad OTH exome
AF:
0.0173
GnomAD4 exome
AF:
0.0120
AC:
17543
AN:
1458644
Hom.:
430
Cov.:
29
AF XY:
0.0129
AC XY:
9380
AN XY:
725942
show subpopulations
African (AFR)
AF:
0.0359
AC:
1198
AN:
33410
American (AMR)
AF:
0.00993
AC:
444
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00682
AC:
178
AN:
26118
East Asian (EAS)
AF:
0.0242
AC:
959
AN:
39688
South Asian (SAS)
AF:
0.0432
AC:
3726
AN:
86182
European-Finnish (FIN)
AF:
0.0866
AC:
4626
AN:
53416
Middle Eastern (MID)
AF:
0.0175
AC:
101
AN:
5764
European-Non Finnish (NFE)
AF:
0.00486
AC:
5386
AN:
1109064
Other (OTH)
AF:
0.0153
AC:
925
AN:
60290
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
857
1714
2571
3428
4285
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
256
512
768
1024
1280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0222
AC:
3375
AN:
152242
Hom.:
80
Cov.:
32
AF XY:
0.0269
AC XY:
2004
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.0344
AC:
1428
AN:
41526
American (AMR)
AF:
0.0106
AC:
162
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00605
AC:
21
AN:
3472
East Asian (EAS)
AF:
0.0120
AC:
62
AN:
5186
South Asian (SAS)
AF:
0.0462
AC:
223
AN:
4824
European-Finnish (FIN)
AF:
0.101
AC:
1067
AN:
10590
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.00537
AC:
365
AN:
68026
Other (OTH)
AF:
0.0180
AC:
38
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
156
313
469
626
782
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00907
Hom.:
54
Bravo
AF:
0.0156
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00467
AC:
18
ESP6500AA
AF:
0.0367
AC:
142
ESP6500EA
AF:
0.00399
AC:
33
ExAC
AF:
0.0216
AC:
2617
Asia WGS
AF:
0.0290
AC:
100
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
May 02, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Joubert syndrome 21 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
3.9
DANN
Benign
0.66
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.0097
N
LIST_S2
Benign
0.69
T;T
MetaRNN
Benign
0.0013
T;T
MetaSVM
Benign
-1.0
T
PhyloP100
-1.4
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.29
N;N
REVEL
Benign
0.019
Sift
Benign
0.37
T;T
Sift4G
Benign
0.38
T;T
Polyphen
0.022
B;B
Vest4
0.071
MPC
0.24
ClinPred
0.0019
T
GERP RS
-5.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.019
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1808140; hg19: chr8-68102977; COSMIC: COSV107262976; API